THE SURVIVAL RATE OF LC IS 15.5%.
THAT’S UNACCEPTABLE. WE’RE
HERE TO CHANGE THAT.

 

Allegro Diagnostics Expands Board and Executive Team

1574R-018939Allegro Diagnostics, a leader in the field of molecular diagnostics for lung cancer, has announced that Stephen Chubb has joined the company’s board of directors and Stephanie Hallam, Ph.D. has joined the company as Vice President of Operations and Quality Systems.

 

Trackback

 

Leave a Reply